US Patent 11851466 Targeted IL-12 heterodimeric Fc-fusion proteins
Patent 11851466 was granted and assigned to Xencor on December, 2023 by the United States Patent and Trademark Office.
All edits
Edits on 27 Dec, 2023
Golden AI
Edits made to:
Infobox (+20 properties)
Article (+157 characters)
US Patent 11851466 Targeted IL-12 heterodimeric Fc-fusion proteins
Article
Patent abstract
The present invention relates to targeted IL-12 heterodimeric Fc fusion proteins, where the fusion proteins bind to human PD-1 or human PD-L1.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
John R. Desjarlais0
Ke Liu0
Matthew Bernett0
Michael Hedvat0
Nargess Hassanzadeh-Kiabi0
Rajat Varma0
Rumana Rashid0
Date of Patent
December 26, 2023
0Patent Application Number
170624580
Date Filed
October 2, 2020
0Patent Citations
Patent Primary Examiner
Find more entities like US Patent 11851466 Targeted IL-12 heterodimeric Fc-fusion proteins
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.